The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis

Figure 2

The mRNA levels of CARM1 in human cancers. (a) Tissues from TCGA and GTEx used for evaluating the mRNA expression of CARM1 between healthy and tumor tissues. (b) The link between the expression of CARM1 mRNA and various pathological phases in patients with various cancers from TCGA. (c) The CARM1 expression in various molecular subtypes of cancers via TISIDB ( value, value, value, and value indicate ≤0.001, ≤0.01, ≤0.05, and ≤0.1, accordingly).

(a)

(b)

(c)